期刊文献+

基质金属蛋白酶-1的研究进展 被引量:13

Progress in the studies of matrix metalloproteinase-1
下载PDF
导出
摘要 基质金属蛋白酶(MMP)是一类由Zn2+依赖性的内肽酶组成的酶家族,降解细胞外基质成分(ECM)。MMP-1是最先完成蛋白纯化和cDNA克隆的脊椎动物胶原酶,以酶原形式合成,通过蛋白水解作用裂解酶原N-端残基,与其他MMP分享一个催化区及一个序列相似于血红素蛋白的羧端。MMP-1是一个多功能分子,不仅参与细胞外间隙胶原纤维的代谢,也参与许多非基质底物和细胞表面分子的分裂。大量证据指出,MMP-1在不同生理、病理进程中起重要作用,如发育、组织形态建成、创伤修复,并与人类多种疾病有关,包括动脉粥样硬化、风湿性关节炎、肺气肿和纤维化等,提示抑制或刺激MMP-1可有助于疾病预防与治疗。 Matrix metalloproteinases (MMP) are a family of Zn^2 + -dependent endopeptidases capable of cleaving components of extracellular matrix (ECM). MMP-1 was the first vertebrate collagenase purified as a protein and cloned as a cDNA, and is considered the prototype for all the interstitial collagenases. It is synthesized as a zymogen. Its N-terminal residues are removed by proteolysis and it shares with other MMPs a catalytic domain and a carboxy terminal domain with the sequence similar to hemopexin. MMP-1 should be considered as a muhifunctional molecule since it participates not only in the turnover of collagen fibrils in the extracellular space but also in the cleavage of a number of nonmatrix substrates and cell surface molecules, suggesting an important role in the regulation of cellular behaviour. Furthermore, an extensive body of evidence indicates that MMP-1 plays an important role in diverse physiologic processes such as growth, tissue morphogenesis, and wound repair. Likewise, it seems to be implicated in a variety of human diseases including atherosclerosis, rheumatoid arthritis, pulmonary emphysema, and fibrotie disorders, suggesting that its inhibition or stimulation may open therapeutic avenues.
出处 《医学研究生学报》 CAS 2006年第11期1028-1031,共4页 Journal of Medical Postgraduates
基金 国家自然科学基金资助项目(批准号:30471649)
关键词 基质金属蛋白酶-1 动脉粥样硬化 多功能分子 Matrix metalloproteinase-1 Atherosclerosis Muhifunctional molecule
  • 相关文献

参考文献17

  • 1Woessner JF, Nagase H. Matrix metalloproteinases and TIMPs[ M ]. New York : Oxford University Press, 2000 : 1-10.
  • 2Puente XP, Sanehez LM, Ovesrall CM, et al. Human and mouse proteases: a comparative genomic approach [ J ]. Nature Review Genetics, 2003, 4 (7) : 544-549.
  • 3Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince [ J ]. Nat Rev Mol Cell Biol,2002, 3(3) : 207-214.
  • 4Vincenti MP, Brinckerhoff CE. Transcriptional regulation of collagenase (MMP-1, MMP-13 ) genes in arthritis: integration of complex signaling pathways for the recruit- ment of gene-specific transcription factors [J]. Arthritis Res, 2002, 4(3) : 157-164.
  • 5Nishioka Y, Sagae S, Nishikawa A, et al. A relationship between matrix metallo-proteinase-1 ( MMP-1 ) promoter polymorphism and cervical cancer progression [ J ]. Cancer Lett, 2003,200( 1 ) : 49-55.
  • 6White LA , Mitchell TI , Brinckerhoff CE. Transforming growth factor beta inhibitory element in the rabbit matrix metalloproteinase-1 (collagenase-1) gene functions as a repressor of constitutive transcription [ J]. Biochim Biophys Acta, 2000, 1490(3) :259-268.
  • 7顾振华,汪俊军,黄宇烽,刘恋,张春妮.低密度脂蛋白循环免疫复合物对U937细胞基质金属蛋白酶-1及其抑制物的作用[J].临床检验杂志,2006,24(2):131-133. 被引量:3
  • 8汪俊军,顾振华,张春妮,范乐明.脂蛋白(a)氧化和自身免疫与动脉粥样硬化的关系[J].医学研究生学报,2005,18(8):740-742. 被引量:22
  • 9McCawley LJ, Matrisian LM. Matrix metalloproteinases: they' re not just for matrix anymore[ J]. Curr Opin Cell Biol, 2001,13(5) : 534-540.
  • 10Miura S, Ohno I, Suzuki J, et al. Inhibition of matrix metallopro-teinases prevents cardiac hypertrophy induced by beta-adrenergic stimulation in rats [ J]. J Cardiovasc Pharmacol, 2003, 42(2) :174-181.

二级参考文献33

  • 1汪俊军,李雯,刘恋,周毓,张春妮,范乐明.氧化低密度脂蛋白循环免疫复合物诱导巨噬细胞胆固醇酯蓄积[J].医学研究生学报,2005,18(3):193-195. 被引量:17
  • 2张春妮,张辰宇,汪俊军,周毓,李文,刘建宁.低密度脂蛋白免疫复合物对小鼠腹腔巨噬细胞胆固醇酯蓄积和一氧化氮释放的影响[J].中国动脉硬化杂志,2005,13(4):397-400. 被引量:2
  • 3Visse R, Nagase H. Matrix metalloproteinase and tissue in hibitors of metalloproteinase:structure, function, and biochemistry[J]. Cite Res,2003,92: 827-839.
  • 4Rajavashish TB, Xu Xp, Jovinge S. Membrance type 1 matrix metalloproteinase expression in human atherosclerotic plaques:evidence for activation by proinflammatory mediators[J]. Circulation, 1999, 99: 3130-3109.
  • 5Hideaki N, Frederick W. Matrix metalloproteinase [J]. J Biol Chem, 1999,274:21491-21494.
  • 6Fenans VJ. New insights into the world of MMPS[J ]. Circulation, 2002, 105: 405-407.
  • 7Lessener SM, Galis Zs. Matrix metalloproteinase and vascular endothelium-mononuclear cell close encounters [J]. Trends Cardiovasc Med, 2004, 14: 105-111.
  • 8Fitigerald M, Hayward IP, Thomas AC, et al. Matrix metalloproteinase can facilitate the heparanase induced promotion of phenotype change in vascular smooth muscle cells [J]. Atherosclerosis, 2000, 149: 97-106.
  • 9Luttun A, Lutgens E, Manderveld A, et al. Loss of matrix met alloproteinsse-9 or matrix metalloproteinsse-12 protects apolipoprotein E-deficent mice against atherosclerotic media destruction but differentially affects plaque growth [J]. Circulation,2004, 109: 1408-1414.
  • 10Sukhova GK, Schubecku, Rabkin E, et al. Evidence for increased collagenolysis by interstitial collagenases -1 and -3 in vulnerable human atheromatous plaques[J]. Circulation, 1999, 99 :2503-2509.

共引文献70

同被引文献205

引证文献13

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部